Home » Topics » BioWorld Science

BioWorld Science
RSS

First patient dosed in phase II study of novel hepcidin mimetic PTG-300

Oct. 31, 2019

Shandong Luoxin Pharmacy Group and Luoxin Pharmaceutical (Shanghai) patent TLR7 agonists

Oct. 31, 2019

Bayer Pharma describes new kallikrein B inhibitors

Oct. 31, 2019

Cyclin-dependant kinase 7 inhibitors discovered by Lead Discovery Center and Qurient

Oct. 31, 2019

Preclinical evaluation of highly potent caspase-cleavable docetaxel prodrug, MPD-03

Oct. 31, 2019

INTH-454: A small molecule modulator of the p300/CBP interactome for cancer

Oct. 31, 2019

(R)-[18F]MH.MZ as a novel PET tracer for the detection of 5-HT2A receptors in the human brain

Oct. 31, 2019

Topline results presented from phase III CMS-001 study of amifampridine phosphate

Oct. 31, 2019

Cyclerion Therapeutics presents topline data from two phase II studies of praliciguat

Oct. 31, 2019

Telix and AusHealth sign agreement for APOMAB molecularly targeted radiation platform

Oct. 31, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...